omega-n-methylarginine has been researched along with cgp 20712a in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (cgp 20712a) | Trials (cgp 20712a) | Recent Studies (post-2010) (cgp 20712a) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 233 | 2 | 25 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, Y; Xu, B | 1 |
1 other study(ies) available for omega-n-methylarginine and cgp 20712a
Article | Year |
---|---|
Different mechanisms mediate beta adrenoceptor stimulated vasorelaxation of coronary and femoral arteries.
Topics: Adrenergic beta-Antagonists; Animals; Arteries; Coronary Vessels; Endothelium, Vascular; Female; Femoral Artery; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Propanolamines; Swine; Vasodilation | 2000 |